CorFlow Names Chris O’Connell as Chairman of the Board
Company - People | May 08, 2025 | Broadview Ventures
CorFlow Therapeutics has announced the appointment of Chris O’Connell as the new Chairman of its Board of Directors. This strategic move aims to bolster the company's leadership as it continues to innovate in its field. CorFlow is known for its pioneering work in healthcare technology, focusing on advancing medical treatments. O’Connell's extensive experience in leadership roles and his track record of steering organizations towards growth and success make him a fitting choice to support CorFlow's objectives. Broadview Ventures, a private equity firm specializing in investments in the healthcare sector, backs CorFlow Therapeutics. The firm's involvement underscores the confidence in CorFlow's potential to make significant advancements in medical technology.
Sectors
- Healthcare Technology
- Private Equity
Geography
- Global – The operations and impacts of CorFlow Therapeutics and Broadview Ventures suggest a global reach due to the nature of healthcare innovations which aim for wide adoption across different markets.
Industry
- Healthcare Technology – CorFlow Therapeutics operates within the healthcare technology sector, focusing on developing advanced medical treatments and innovations.
- Private Equity – Broadview Ventures, the private equity firm backing CorFlow Therapeutics, is involved in this sector, highlighting its focus on strategic investments in healthcare companies.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| CorFlow Therapeutics | Target Company | Company | A healthcare technology company known for developing advanced medical treatments. |
| Chris O’Connell | Chairman of the Board | Person | Recently appointed as Chairman of CorFlow Therapeutics' Board of Directors. |
| Broadview Ventures | Private Equity Firm | Company | A PE firm specializing in investments within the healthcare sector, providing backing to CorFlow Therapeutics. |